Yongjun Cha

Trastuzumab deruxtecan in patients with HER2-positive advanced colorectal cancer (DESTINY-CRC02): primary results from a multicentre, randomised, phase 2 trial

Kanwal Raghav, Salvatore Siena, Atsuo Takashima et al. · The Lancet Oncology · 2024 · 126 citations

Medicine, Oncology, Pharmacology +13

Serum neurofilament light chain levels as a biomarker of neuroaxonal injury and severity of oxaliplatin-induced peripheral neuropathy

Su‐Hyun Kim, Moon Ki Choi, Na-Young Park et al. · Scientific Reports · 2020 · 91 citations · Full text

Medicine, Neurology, Oncology +17

Therapeutic implication of HER2 in advanced biliary tract cancer

Ah‐Rong Nam, Ji‐Won Kim, Yongjun Cha et al. · Oncotarget · 2016 · 86 citations · Full text

Medicine, Oncology, Pharmacology +17

Cancer Patients’ Willingness to Take COVID-19 Vaccination: A Nationwide Multicenter Survey in Korea

June Young Chun, Se Ik Kim, Eun Young Park et al. · Cancers · 2021 · 65 citations · Full text

Veterinary Medicine, Infectious Diseases, Oncology +14

Association between mutations of critical pathway genes and survival outcomes according to the tumor location in colorectal cancer

Dae‐Won Lee, Sae‐Won Han, Yongjun Cha et al. · Cancer · 2017 · 60 citations · Full text

Medicine, Molecular Medicine, Oncology +17